:

FUNDS RACE TO ATTRACT RETAIL INVESTORS AHEAD OF SPACEX IPO

AI DESK1 MIN READ
TUE, APR 28, 2026

■ AI-SUMMARIZED FROM 2 SOURCES ▸ TIMELINE

Investment funds are aggressively courting retail investors in secondary markets ahead of SpaceX's anticipated public offering. High demand has pushed valuations to extreme levels, with one fund trading at a 3,000% premium to its net asset value.

SpaceX's path to going public has triggered a frenzy among funds seeking to offer retail exposure to the rocket company before its IPO. Secondary market funds holding SpaceX shares are marketing aggressively to individual investors, capitalizing on widespread interest in the private company. The valuation spike reflects intense demand—one fund reached a 3,000% premium over its actual net asset value, a stark indicator of how eager investors are to gain exposure to SpaceX ahead of any public listing. SpaceX, valued at $180 billion in recent private funding rounds, has not announced IPO plans. However, CEO Elon Musk has previously suggested the company could go public once cash flow becomes more predictable. Retail investors face risks in secondary markets, including illiquidity and inflated valuations. Fund managers are leveraging SpaceX's brand recognition and Musk's prominence to drive investments, even as uncertainty remains about timing and terms of a potential IPO.

■ SOURCES

Bloomberg TechBloomberg Tech

■ SUMMARY WRITTEN BY AI FROM THE LINKS ABOVE

■ MORE FROM THE STARTUPS DESK

Triomics, an AI platform automating data-heavy tasks for oncologists, secured $22M in Series B funding. The raise follows a $15M Series A in 2024.

22H AGOAI Desk

Xcena secured $135 million in Series B funding at a $570 million valuation for its MX1 chip, which handles data orchestration and KV cache management directly within memory modules.

22H AGOAI Desk

Pittsburgh-based Gray Swan, which stress-tests AI models for frontier labs, secured $40M in Series A funding at a $200M valuation. The round was co-led by Wing VC and Madrona.

YESTERDAYAI Desk

H1, a healthcare SaaS startup, secured $40 million in funding from CVS Health. The investment signals continued investor confidence in specialized software platforms despite AI disruption concerns.

YESTERDAYIndustry Desk

■ SUBSCRIBE TO THE DAILY BRIEF

ONE EMAIL, 5 STORIES, 06:00 UTC. UNSUBSCRIBE ANYTIME.